PRQR,SWZ,SNES Stock Price and Quote

Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

Peers: KPTI ADAG CAMP CNTN CNTX IFRX PLYX RNA TENX TLSA

Index	-
Market Cap	223.42M
Enterprise Value	145.76M
Income	-52.71M
Sales	15.53M
Book/sh	0.41
Cash/sh	0.70
Dividend Est.	-
Dividend TTM	-
Dividend Ex-Date	-
Dividend Gr. 3/5Y	- -
Payout	-
Employees	-
IPO	Sep 18, 2014

P/E	-
Forward P/E	-
PEG	-
P/S	14.39
P/B	4.09
P/C	2.39
P/FCF	-
EV/EBITDA	-
EV/Sales	9.39
Quick Ratio	2.48
Current Ratio	2.48
Debt/Eq	0.36
LT Debt/Eq	0.24
Option/Short	Yes / Yes

EPS (ttm)	-0.50
EPS next Y	-0.57
EPS next Q	-0.13
EPS this Y	-14.57%
EPS next Y	-9.31%
EPS next 5Y	4.76%
EPS past 3/5Y	21.80% 15.68%
Sales past 3/5Y	68.13% -
EPS Y/Y TTM	-44.36%
Sales Y/Y TTM	-23.73%
EPS Q/Q	-47.57%
Sales Q/Q	-49.99%
Earnings	May 12 BMO
EPS/Sales Surpr.	-9.12% -54.37%

Insider Own	32.35%
Insider Trans	0.70%
Inst Own	26.99%
Inst Trans	-1.63%
ROA	-37.92%
ROE	-81.98%
ROIC	-98.02%
Gross Margin	79.71%
Oper. Margin	-346.94%
Profit Margin	-339.39%
SMA20	0.64%
SMA50	5.15%
SMA200	-10.94%
Trades

Shs Outstand	105.36M
Shs Float	89.97M
Short Float	1.12%
Short Ratio	1.08
Short Interest	1.01M
52W High	3.10 -45.81%
52W Low	1.33 26.32%
Volatility	10.97% 11.12%
ATR (14)	0.17
RSI (14)	50.63
Beta	0.07
Rel Volume	2.63
Avg Volume	938.38K
Volume	2,470,269

Perf Week	-9.68%
Perf Month	12.00%
Perf Quarter	-1.18%
Perf Half Y	-17.65%
Perf YTD	-16.83%
Perf Year	-23.64%
Perf 3Y	-1.18%
Perf 5Y	-73.33%
Perf 10Y	-64.78%
Recom	1.00
Target Price	8.99
Prev Close	1.66
Price	1.68
Change	1.20%

Date	Action	Analyst	Rating Change	Price Target Change
Mar-12-26	Resumed	Oppenheimer	Outperform	$9
Apr-29-25	Resumed	Cantor Fitzgerald	Overweight	$8
Apr-29-25	Initiated	Evercore ISI	Outperform	$5
Mar-10-25	Upgrade	Citigroup	Neutral → Buy	$4
Jan-10-25	Initiated	Oppenheimer	Outperform	$15
Oct-29-24	Upgrade	Raymond James	Outperform → Strong Buy	$6 → $14
Nov-08-23	Upgrade	Chardan Capital Markets	Neutral → Buy	$2
Mar-30-23	Upgrade	JMP Securities	Mkt Perform → Mkt Outperform	$1.50 → $5
Dec-22-22	Upgrade	Cantor Fitzgerald	Neutral → Overweight	$0.80 → $5
Feb-14-22	Downgrade	Citigroup	Buy → Neutral	$37 → $1.70
Feb-11-22	Downgrade	Stifel	Buy → Hold	$20 → $3
Feb-11-22	Downgrade	Raymond James	Strong Buy → Mkt Perform
Feb-01-22	Initiated	Raymond James	Strong Buy	$19
May-03-21	Initiated	Stifel	Buy	$20
Mar-25-21	Reiterated	Citigroup	Buy	$33 → $44
Nov-03-20	Resumed	Cantor Fitzgerald	Overweight	$22
Mar-12-19	Reiterated	Chardan Capital Markets	Buy	$21 → $25
Dec-19-18	Initiated	RBC Capital Mkts	Outperform
Nov-15-18	Initiated	Citigroup	Buy	$32
Sep-19-18	Initiated	Evercore ISI	Outperform

Show Previous Ratings

Jun-25-26 06:35AM	ProQR Prices $50.0 Million Underwritten Registered Direct Offering and Concurrent Private Placement (GlobeNewswire) -13.54%
06:25AM	ProQR Announces Positive Phase 1 Target Engagement Data for AX-0810, Establishing First Clinical Validation of the Axiomer RNA Editing Platform (GlobeNewswire)
May-12-26 07:00AM	ProQR Announces First Quarter 2026 Operating and Financial Results (GlobeNewswire)
May-11-26 08:00AM	ProQR Announces Multiple Upcoming Scientific Conference Presentations Highlighting the Breadth of its Axiomer RNA Editing Platform (GlobeNewswire)
May-04-26 08:00AM	ProQR Announces Annual General Meeting of Shareholders to be Held June 2, 2026 (GlobeNewswire) +5.81%
08:00AM	Loading…
Apr-30-26 08:00AM	ProQR Announces Nomination of Dr. Lykke Hinsch Gylvin to its Board of Directors (GlobeNewswire)
Apr-08-26 04:00PM	ProQR Highlights Pipeline Expansion and Multiple Upcoming Clinical Catalysts at Investor and Analyst Event (GlobeNewswire) +7.65% +8.20%
08:00AM	ProQR Announces Partnership with Ginkgo Bioworks and Formation of AI Advisory Board (GlobeNewswire)
Mar-25-26 08:00AM	ProQR to Host Virtual Investor and Analyst Event Highlighting Pipeline on April 8, 2026 (GlobeNewswire) +6.04%
Mar-12-26 09:18AM	ProQR: Q4 Earnings Snapshot (Associated Press Finance)
07:00AM	ProQR Announces Year End 2025 Operating and Financial Results (GlobeNewswire)
Mar-10-26 08:30AM	Opus Genetics, Inc. (IRD) Reports Q4 Loss, Tops Revenue Estimates (Zacks)
Mar-03-26 04:30PM	ProQR Announces Webcast of Presentation at the 2026 Citizens Life Sciences Conference (GlobeNewswire) -5.06% +13.33%
Feb-26-26 06:45PM	Puma Biotech (PBYI) Q4 Earnings and Revenues Beat Estimates (Zacks)
Feb-09-26 08:00AM	ProQR Announces Planned Changes to Board Composition (GlobeNewswire)
08:00AM	Loading…
Jan-08-26 08:00AM	ProQR Announces Encouraging AX-0810 Phase 1 Safety and PK Data, Development Candidate Selections, and 2026 Outlook (GlobeNewswire)
Dec-01-25 08:00AM	ProQR to Participate in 8th Annual Evercore Healthcare Conference (GlobeNewswire) -9.40%
Nov-06-25 08:10AM	ProQR (PRQR) Reports Q3 Loss, Misses Revenue Estimates (Zacks) -7.14%
07:08AM	ProQR: Q3 Earnings Snapshot (Associated Press Finance)
07:00AM	ProQR Announces Third Quarter 2025 Operating and Financial Results (GlobeNewswire)
Oct-28-25 08:20AM	Alkermes (ALKS) Surpasses Q3 Earnings and Revenue Estimates (Zacks)
Oct-20-25 08:00AM	ProQR Receives CTA Authorization for AX-0810 and Announces Virtual Investor and Analyst Event on November 3, 2025 (GlobeNewswire) +9.71%
Oct-13-25 08:30AM	ProQR to Participate in Upcoming Investor Conferences in October 2025 (GlobeNewswire)
Aug-08-25 02:02PM	ProQR: Q2 Earnings Snapshot (Associated Press Finance) +5.85%
Aug-07-25 08:40AM	Intellia Therapeutics, Inc. (NTLA) Reports Q2 Loss, Beats Revenue Estimates (Zacks)
07:00AM	ProQR Announces Second Quarter 2025 Operating and Financial Results (GlobeNewswire)
Jul-28-25 08:00AM	ProQR Announces Upcoming Presentation at RNA Editing Summit (GlobeNewswire)
Jun-26-25 04:30PM	ProQR Announces CTA Submission for Phase 1 Study of AX-0810 Targeting NTCP (GlobeNewswire) -5.56%
May-12-25 08:00AM	ProQR Announces Upcoming Scientific Presentations at ASGCT and TIDES Conferences (GlobeNewswire)
May-08-25 07:00AM	ProQR Announces First Quarter 2025 Operating and Financial Results (GlobeNewswire)
07:40AM	Loading…
May-07-25 07:40AM	Techne (TECH) Q3 Earnings and Revenues Beat Estimates (Zacks)
May-02-25 08:00AM	ProQR Announces Webcast of Presentation at the 2025 Citizens Life Sciences Conference (GlobeNewswire) +15.70%
May-01-25 08:00AM	ProQR Announces Annual General Meeting of Shareholders to be Held June 3, 2025 (GlobeNewswire)
Apr-29-25 04:31PM	ProQR Therapeutics assumed with an Overweight at Cantor Fitzgerald (TipRanks) +5.84%
04:05PM	ProQR Therapeutics initiated with an Outperform at Evercore ISI (TipRanks)
Apr-15-25 09:01AM	Strength Seen in BioNTech (BNTX): Can Its 6.0% Jump Turn into More Strength? (Zacks)
Apr-14-25 07:00AM	ProQR Strengthens Leadership with Appointments of CFO and CMO to Support Next Phase of Growth (GlobeNewswire) +5.36%
Mar-13-25 07:00AM	ProQR Announces Year End 2024 Operating and Financial Results (GlobeNewswire) -5.95%
Dec-12-24 07:16AM	ProQR Therapeutics announces $8.1M in new funding from RSRT (TipRanks)
Dec-11-24 07:00AM	ProQR Therapeutics Announces $8.1 Million in New Funding from Rett Syndrome Research Trust to Expand RNA Editing Collaboration (GlobeNewswire)
Dec-10-24 08:00AM	ProQR Appoints Peter A. Beal, PhD, as Chief ADAR Scientist (GlobeNewswire)
Dec-06-24 06:47AM	ProQR Therapeutics price target raised to $8 from $5 at JMP Securities (TipRanks)
Dec-05-24 08:00AM	ProQR Therapeutics to Host Virtual Analyst and Investor Event on December 11, 2024 (GlobeNewswire)
Nov-08-24 07:26AM	ProQR Therapeutics sees cash runway into mid-2027 (TipRanks) +5.60%
Nov-07-24 07:00AM	ProQR Announces Third Quarter 2024 Operating and Financial Results (GlobeNewswire)
Oct-25-24 04:45PM	ProQR Announces Closing of Underwritten Public Offering and Concurrent Private Placement (GlobeNewswire)
Oct-22-24 10:15PM	ProQR Prices $75 Million Underwritten Public Offering and Concurrent Private Placement (GlobeNewswire) -6.67% -7.67%
04:01PM	ProQR Announces Proposed Underwritten Public Offering of Ordinary Shares (GlobeNewswire)
Oct-07-24 08:00AM	ProQR Highlights Upcoming Presentation at 20th Annual Meeting of the Oligonucleotide Therapeutics Society (GlobeNewswire)
Sep-10-24 04:30PM	ProQR Announces Webcast Presentation at the 2024 Cantor Global Healthcare Conference (GlobeNewswire)
Aug-08-24 07:00AM	ProQR Announces Second Quarter 2024 Operating and Financial Results (GlobeNewswire) +12.30%
Jun-18-24 08:00AM	ProQR Announces Presentation on its Axiomer RNA Editing Technology at RNA Editing Summit (GlobeNewswire)
May-09-24 07:00AM	ProQR Announces First Quarter 2024 Operating and Financial Results (GlobeNewswire)
May-08-24 08:00AM	ProQR Announces Preclinical Proof of Concept Data for AX-0810 Axiomer RNA Editing Program Targeting NTCP for Cholestatic Diseases (GlobeNewswire)
Apr-23-24 07:00AM	ProQR Nominates Martin Maier, PhD to Board and Announces Annual Meeting of Shareholders to be Held May 22, 2024 (GlobeNewswire)
Apr-22-24 04:31PM	ProQR Highlights Upcoming Presentations on Axiomer RNA Editing at ASGCT 27th Annual Meeting (GlobeNewswire)
Apr-19-24 07:00AM	ProQR Achieves Successful Defense of New Challenge to its Axiomer IP Portfolio (GlobeNewswire) +6.99%
Mar-13-24 07:00AM	ProQR Announces Year End 2023 Operating and Financial Results (GlobeNewswire) +13.66%
Feb-15-24 07:00AM	ProQR Announces Japanese Axiomer Patent Upheld Following Opposition Against Its Leading IP Estate for ADAR-mediated RNA Editing (GlobeNewswire)
Jan-19-24 07:00AM	ProQR Highlights New Platform Data from Presentation on Axiomer RNA Editing Technology at Deaminet 2024 (GlobeNewswire)
Jan-05-24 07:00AM	ProQR and Rett Syndrome Research Trust Join Forces with Axiomer RNA Editing Collaboration (GlobeNewswire)
Dec-28-23 08:44AM	Is ProQR (PRQR) Stock a Solid Choice Right Now? (Zacks)
Dec-08-23 07:30AM	ProQR Therapeutics Announces Transaction Completed for Th a to Acquire Sepofarsen and Ultevursen Ophthalmic Assets (GlobeNewswire)
Nov-07-23 07:00AM	ProQR Announces Third Quarter 2023 Operating and Financial Results (GlobeNewswire) +10.66%
Nov-06-23 07:00AM	ProQR Strengthens Leading Intellectual Property Estate for ADAR-mediated RNA Editing (GlobeNewswire)
Sep-28-23 08:00AM	ProQR Announces Participation in the Chardan 7th Annual Genetic Medicines Conference (GlobeNewswire)
Sep-27-23 07:00AM	ProQR Therapeutics Provides Update on Ophthalmic Assets (GlobeNewswire)
Sep-07-23 08:00AM	ProQR Announces Webcast of Presentation at the Upcoming HC Wainwright 25th Annual Global Investment Conference (GlobeNewswire)
Aug-08-23 06:37AM	ProQR Therapeutics N.V.'s (NASDAQ:PRQR) top owners are retail investors with 50% stake, while 31% is held by institutions (Simply Wall St.)
Aug-03-23 07:00AM	ProQR Announces Second Quarter 2023 Operating and Financial Results (GlobeNewswire)
Aug-01-23 07:00AM	ProQR Therapeutics and Laboratoires Théa Announce Agreement for Théa to Acquire ProQRs Sepofarsen and Ultevursen Ophthalmic Assets (GlobeNewswire) +7.33%
Jul-06-23 07:00AM	ProQR to Present Data on its Axiomer® RNA Editing Technology at RNA Editing Summit (GlobeNewswire)
Jun-28-23 06:02AM	ProQR Therapeutics' (NASDAQ:PRQR) investors will be pleased with their impressive 109% return over the last year (Simply Wall St.)
May-18-23 07:02AM	ProQR Therapeutics N.V. (NASDAQ:PRQR) Could Be Less Than A Year Away From Profitability (Simply Wall St.)
May-16-23 07:00AM	ProQR Announces First Quarter 2023 Operating and Financial Results (GlobeNewswire) -7.29%
May-09-23 08:00AM	ProQR to Present its Axiomer® RNA Editing Technology at TIDES USA 2023 (GlobeNewswire)
Apr-20-23 08:00AM	ProQR Announces Upcoming Investor Conferences in April and May (GlobeNewswire)
Apr-18-23 08:00AM	ProQR Announces Annual Meeting of Shareholders to be Held May 17, 2023 (GlobeNewswire) -6.47%
Mar-29-23 12:30PM	Why Shares of ProQR Therapeutics Dropped on Wednesday (Motley Fool) -29.61%
08:00AM	ProQR Announces Initial Pipeline Targets and Highlights Axiomer® RNA Editing Platform Technology at R&D Event (GlobeNewswire)
Mar-14-23 08:00AM	ProQR Announces Successful Defense of a Key Axiomer® Patent Protecting ADAR-mediated RNA Editing (GlobeNewswire) +7.85%
Mar-07-23 08:00AM	ProQR to Present at Upcoming Scientific and Industry Conferences (GlobeNewswire)
Feb-28-23 08:00AM	ProQR Therapeutics to Host Virtual R&D Event on March 29, 2023 (GlobeNewswire)
Feb-01-23 05:11AM	Individual investors account for 45% of ProQR Therapeutics N.V.'s (NASDAQ:PRQR) ownership, while institutions account for 35% (Simply Wall St.)
Dec-29-22 11:36AM	Biotech Stock Roundup: GILD's HIV Drug Approval, PRQR Surges on LLY Deal & More (Zacks) +10.13%
Dec-23-22 12:14PM	ProQR (PRQR) Rises on Expanding RNA-Editing Deal With Eli Lilly (Zacks)
Dec-22-22 09:12AM	ProQR's stock jumps on expanded RNA deal with Lilly (MarketWatch) +63.64%
08:53AM	ProQR Therapeutics Shares Soar As Eli Lilly Expands RNA Collaboration (Benzinga)
06:15AM	ProQR Announces Conference Call to Discuss Axiomer® RNA Editing Platform (GlobeNewswire)
06:00AM	Lilly and ProQR to Expand RNA Editing Collaboration (PR Newswire)
05:28AM	ProQR Therapeutics (NASDAQ:PRQR) shareholders have endured a 83% loss from investing in the stock three years ago (Simply Wall St.)
Nov-14-22 04:30PM	ProQR to Present its Axiomer® RNA Editing Technology at the Oligonucleotide and Peptide Therapeutics Conference (TIDES Europe) 2022 (GlobeNewswire) +5.18%
Nov-11-22 05:54AM	ProQR Therapeutics Third Quarter 2022 Earnings: Revenues Beat Expectations, EPS Lags (Simply Wall St.)
Nov-09-22 08:25AM	ProQR (PRQR) Reports Q3 Loss, Lags Revenue Estimates (Zacks)
07:00AM	ProQR Announces Third Quarter 2022 Operating and Financial Results (GlobeNewswire)
Nov-03-22 07:00AM	ProQR Announces Webcast of Presentation at the Upcoming Stifel 2022 Healthcare Conference (GlobeNewswire)
Aug-12-22 02:05PM	Raymond James Bullish On This Penny Stock's Reprioritized Pipeline (Benzinga) +5.51%
Aug-11-22 02:48PM	This Penny Stock Biotech Offloads Eye Portfolio To Focus On RNA-Editing (Benzinga)
07:00AM	ProQR to Focus Exclusively on Axiomer RNA-editing Technology and Partner Ophthalmology Programs (GlobeNewswire)
Aug-04-22 10:25AM	ProQR (PRQR) Reports Q2 Loss, Lags Revenue Estimates (Zacks)

ProQR Therapeutics NV is a clinical stage biopharmaceutical company, which engages in the discovery and development of RNA therapies for the treatment of severe genetic rare diseases with a focus on inherited retinal diseases. The company was founded by Daniel Anton de Boer, Gerard J. Platenburg, Henri A. Termeer, and Domenico Valerio on February 21, 2012, and is headquartered in Leiden, the Netherlands.

FounderMr. Daniel Anton de Boer

Co-FounderDr. Gerard Platenburg Ph.D.

Chief Financial OfficerMr. Dennis Hom

Chief People & Operations OfficerMs. Sheila Sponselee

Vice President of Investor Relations & Corporate CommunicationsMs. Sarah Cue Kiely

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
de Boer Daniel Anton	Chief Executive Officer	Jul 07 '26	Buy	1.59	150,000	238,500	150,000	Jul 08 02:55 PM
Filius Bart	Director	Jun 26 '26	Buy	1.54	150,000	231,000	150,000	Jun 30 04:01 PM

SWZ Total Return Securities Fund daily Stock Chart

Peers: CAF EEA GF TWN MXF

| Held by: CEFS CEFZ

Index	-
Market Cap	76.93M
Enterprise Value	-
Income	-
Sales	-
Book/sh	-
Cash/sh	-
Dividend Est.	-
Dividend TTM	-
Dividend Ex-Date	Apr 15, 2025
Dividend Gr. 3/5Y	- -
Payout	-
Employees	-
IPO	Aug 19, 1987

P/E	-
Forward P/E	-
PEG	-
P/S	-
P/B	-
P/C	-
P/FCF	-
EV/EBITDA	-
EV/Sales	-
Quick Ratio	-
Current Ratio	-
Debt/Eq	-
LT Debt/Eq	-
Option/Short	No / Yes

EPS (ttm)	-
EPS next Y	-
EPS next Q	-
EPS this Y	-
EPS next Y	-
EPS next 5Y	-
EPS past 3/5Y	- -
Sales past 3/5Y	- -
EPS Y/Y TTM	-
Sales Y/Y TTM	-
EPS Q/Q	-
Sales Q/Q	-
Earnings	-
EPS/Sales Surpr.	- -

Insider Own	-
Insider Trans	-
Inst Own	-
Inst Trans	-
ROA	-
ROE	-
ROIC	-
Gross Margin	-
Oper. Margin	-
Profit Margin	-
SMA20	0.03%
SMA50	-0.64%
SMA200	-1.74%
Trades

Shs Outstand	12.97M
Shs Float	12.79M
Short Float	0.13%
Short Ratio	0.21
Short Interest	0.02M
52W High	6.43 -7.78%
52W Low	5.84 1.54%
Volatility	1.00% 0.72%
ATR (14)	0.05
RSI (14)	48.26
Beta	0.71
Rel Volume	0.35
Avg Volume	78.42K
Volume	27,071

Perf Week	-0.17%
Perf Month	1.19%
Perf Quarter	-0.67%
Perf Half Y	-4.66%
Perf YTD	-4.66%
Perf Year	-5.42%
Perf 3Y	8.28%
Perf 5Y	-10.76%
Perf 10Y	-14.19%
Recom	-
Target Price	-
Prev Close	5.98
Price	5.93
Change	-0.84%

Mar-27-26 04:32PM	Total Return Securities Fund Announces Annual Meeting (GlobeNewswire)
Jan-22-26 09:33AM	Total Return Securities Fund Announces Final Pricing of Tender Offer (GlobeNewswire)
Jan-21-26 07:46AM	Total Return Securities Fund Announces Results of Tender Offer (GlobeNewswire)
Dec-19-25 04:35PM	Total Return Securities Fund Announces Commencement of a Cash Tender Offer (GlobeNewswire)
Dec-08-25 07:56AM	Total Return Securities Fund Announces Expiration of Rights Offering (GlobeNewswire)
03:50PM	Loading…
Nov-03-25 03:50PM	Total Return Securities Fund Provides Details About Rights Offering and Subsequent Tender Offer (GlobeNewswire)
Aug-19-25 04:10PM	Total Return Securities Fund, Inc. Announces Rights Offering (GlobeNewswire)
Aug-07-25 04:00PM	Total Return Securities Fund, Inc. Makes Announcement (GlobeNewswire)
Jun-05-25 01:50AM	TOTAL RETURN SECURITIES FUND PORTFOLIO SNAPSHOT (PR Newswire)
Apr-21-25 08:47PM	TOTAL RETURN SECURITIES FUND PORTFOLIO SNAPSHOT (PR Newswire)
Mar-24-25 08:07PM	THE SWISS HELVETIA FUND, INC. DECLARES SPECIAL DISTRIBUTION OF $3.00 PER SHARE (PR Newswire)
Mar-07-25 06:18PM	THE SWISS HELVETIA FUND, INC. DECLARES QUARTERLY DISTRIBUTION OF $0.1458 PER SHARE (PR Newswire)
Feb-21-25 04:10PM	The Swiss Helvetia Fund Announces Results of Special Meeting (GlobeNewswire)
Jan-27-25 02:57PM	The Swiss Helvetia Fund Announces Special Meeting (GlobeNewswire)
Jan-10-25 04:15PM	The Swiss Helvetia Fund Announces Special Meeting (GlobeNewswire) +5.78%
01:22PM	Loading…
Dec-06-24 01:22PM	THE SWISS HELVETIA FUND, INC. DECLARES QUARTERLY DISTRIBUTION AT NEW RATE OF $0.1458 PER SHARE (PR Newswire)
Oct-23-24 03:55PM	THE SWISS HELVETIA FUND, INC. ANNOUNCES RESULTS OF THE 2024 ANNUAL MEETING OF STOCKHOLDERS (PR Newswire)
Sep-06-24 04:20PM	THE SWISS HELVETIA FUND, INC. DECLARES QUARTERLY DISTRIBUTION OF $0.129 PER SHARE (PR Newswire)
Jun-07-24 03:09PM	THE SWISS HELVETIA FUND, INC. DECLARES QUARTERLY DISTRIBUTION OF $0.129 PER SHARE (PR Newswire)
Mar-08-24 09:05AM	THE SWISS HELVETIA FUND, INC. DECLARES QUARTERLY DISTRIBUTION OF $0.129 PER SHARE (PR Newswire)
Dec-08-23 03:25PM	THE SWISS HELVETIA FUND, INC. DECLARES QUARTERLY DISTRIBUTION AT NEW RATE OF $0.129 PER SHARE (PR Newswire)
Sep-19-23 12:22PM	Swiss Helvetia Fund Inc (SWZ): A Closer Look at Its Dividend Performance and Sustainability (GuruFocus.com)
Sep-15-23 11:13AM	THE SWISS HELVETIA FUND, INC. ANNOUNCES RESULTS OF THE 2023 ANNUAL MEETING OF STOCKHOLDERS (PR Newswire)
Sep-07-23 12:23PM	THE SWISS HELVETIA FUND, INC. DECLARES QUARTERLY CASH DISTRIBUTION OF $0.12285 PER SHARE (PR Newswire)
Jun-09-23 09:53AM	THE SWISS HELVETIA FUND, INC. DECLARES QUARTERLY CASH DISTRIBUTION OF $0.12285 PER SHARE (PR Newswire)
Mar-09-23 02:40PM	THE SWISS HELVETIA FUND, INC. DECLARES QUARTERLY DISTRIBUTION OF $0.12285 PER SHARE (PR Newswire)
Dec-16-22 04:00PM	THE SWISS HELVETIA FUND, INC. ANNOUNCES 2023 REPURCHASE PROGRAM (PR Newswire)
Dec-09-22 11:10AM	THE SWISS HELVETIA FUND, INC. DECLARES QUARTERLY DISTRIBUTION AT NEW RATE OF $0.12285 PER SHARE (PR Newswire)
Sep-16-22 05:15PM	THE SWISS HELVETIA FUND, INC. ANNOUNCES RESULTS OF THE 2022 ANNUAL MEETING OF STOCKHOLDERS (PR Newswire)
Sep-08-22 01:19PM	THE SWISS HELVETIA FUND, INC. DECLARES QUARTERLY DISTRIBUTION OF $0.1665 PER SHARE (PR Newswire)
09:50AM	Loading…
Jun-07-22 09:50AM	THE SWISS HELVETIA FUND, INC. DECLARES QUARTERLY DISTRIBUTION OF $0.1665 PER SHARE (PR Newswire)
Apr-01-22 04:00PM	THE SWISS HELVETIA FUND, INC. ANNOUNCES NEW CREDIT AGREEMENT (PR Newswire)
Mar-04-22 09:33AM	THE SWISS HELVETIA FUND, INC. DECLARES QUARTERLY DISTRIBUTION OF $0.1665 PER SHARE (PR Newswire)
Dec-13-21 11:35AM	THE SWISS HELVETIA FUND, INC. ANNOUNCES 2022 REPURCHASE PROGRAM (PR Newswire)
Dec-10-21 04:31PM	THE SWISS HELVETIA FUND, INC. DECLARES QUARTERLY DISTRIBUTION AT NEW RATE OF $0.1665 PER SHARE (PR Newswire)
Sep-14-21 06:48PM	The Swiss Helvetia Fund, Inc. Announces Results Of The 2021 Annual Meeting Of Stockholders (PR Newswire)
Sep-09-21 11:50AM	The Swiss Helvetia Fund, Inc. Declares Quarterly Distribution Of $0.13755 Per Share (PR Newswire)
Aug-19-21 02:11PM	The Swiss Helvetia Fund, Inc. Announces New Location For 2021 Annual Meeting Of Stockholders (PR Newswire)
Jun-10-21 11:22AM	The Swiss Helvetia Fund, Inc. Declares Quarterly Distribution of $0.13755 Per Share (PR Newswire)
Mar-12-21 04:15PM	The Swiss Helvetia Fund, Inc. Declares Quarterly Distribution Of $0.13755 Per Share (PR Newswire)
Nov-25-20 04:01PM	The Swiss Helvetia Fund, Inc. Declares Quarterly Distribution At New Rate Of $0.13755 Per Share (PR Newswire)
Sep-16-20 03:48PM	The Swiss Helvetia Fund, Inc. Announces Results Of The 2020 Annual Meeting Of Stockholders (PR Newswire)
Sep-11-20 03:16PM	The Swiss Helvetia Fund, Inc. Declares Quarterly Distribution Of $0.1404 Per Share (PR Newswire)
Aug-31-20 05:34PM	The Swiss Helvetia Fund, Inc. Announces New Location For 2020 Annual Meeting Of Stockholders (PR Newswire)
Jun-10-20 05:11PM	The Swiss Helvetia Fund, Inc. Declares Quarterly Distribution of $0.1404 Per Share (PR Newswire)
Mar-10-20 06:12PM	The Swiss Helvetia Fund, Inc. Declares Quarterly Distribution Of $0.1404 Per Share (PR Newswire)
Jan-14-20 12:16PM	The Swiss Helvetia Fund, Inc. Announces Estimated Distribution Sources (PR Newswire)
Dec-13-19 08:25AM	The Swiss Helvetia Fund, Inc. Announces 2020 Repurchase Program (PR Newswire)
Dec-06-19 11:50AM	The Swiss Helvetia Fund, Inc. Declares Quarterly Distribution Of $0.1404 Per Share (PR Newswire)
Nov-07-19 04:57PM	The Swiss Helvetia Fund, Inc. Announces Resumption of Managed Distribution Plan (PR Newswire)
Nov-01-19 09:52AM	The Swiss Helvetia Fund, Inc. Announces Results Of The 2019 Annual Meeting Of Stockholders (PR Newswire)
Oct-04-19 04:45PM	The Swiss Helvetia Fund, Inc. Announces Adjournment Of 2019 Annual Meeting Of Stockholders To October 31, 2019 (PR Newswire)
Jul-29-19 06:12PM	The Swiss Helvetia Fund, Inc. Announces Filing Of Preliminary Proxy Materials; Proposal For Expanded Fund Mandate And Approval Of Investment Advisory Agreement With Bulldog Investors, LLC (PR Newswire)
Jan-25-19 04:40PM	The Swiss Helvetia Fund, Inc. Announces New Executive Officers (PR Newswire)
Dec-07-18 05:40PM	The Swiss Helvetia Fund, Inc. Announces 2019 Repurchase Program And Continued Suspension Of Managed Distribution Plan (PR Newswire)
Nov-20-18 01:00PM	The Swiss Helvetia Fund, Inc. Announces Final Results Of Cash Tender Offer (PR Newswire)
Nov-19-18 06:00AM	The Swiss Helvetia Fund, Inc. Announces Expiration And Preliminary Results Of Cash Tender Offer (PR Newswire)
Oct-22-18 06:07PM	The Swiss Helvetia Fund, Inc. Announces Commencement Of One-Time Cash Tender Offer (PR Newswire)
Oct-17-18 06:38PM	The Swiss Helvetia Fund, Inc. Announces Details Of Stock Dividend Payable On October 19, 2018 (PR Newswire)
Sep-07-18 04:55PM	The Swiss Helvetia Fund, Inc. Declares Stock Dividend (PR Newswire)
Aug-23-18 04:30PM	The Swiss Helvetia Fund, Inc. Announces Tender Offer and Stock Dividend (PR Newswire)
Jul-20-18 04:10PM	The Swiss Helvetia Fund, Inc. Announces Director Replacement (PR Newswire)
Jul-03-18 01:32PM	The Swiss Helvetia Fund, Inc. Announces Final Results of 2018 Annual Stockholder Meeting (PR Newswire)
Jun-29-18 04:15PM	The Swiss Helvetia Fund, Inc. Announces Payment Of Quarterly Distribution And Releases Estimated Distribution Sources (PR Newswire)
Jun-25-18 04:15PM	The Swiss Helvetia Fund, Inc. Announces Preliminary Results Of 2018 Annual Stockholder Meeting (PR Newswire)
Jun-12-18 04:15PM	The Swiss Helvetia Fund, Inc. Declares Quarterly Distribution Of $0.2025 Per Share (PR Newswire)
Jun-08-18 05:44PM	The Swiss Helvetia Fund, Inc. Announces ISS And Glass Lewis Voting Recommendations For 2018 Annual Stockholder Meeting (PR Newswire)
May-29-18 05:44PM	The Swiss Helvetia Fund, Inc. Announces Adoption Of Managed Distribution Plan (PR Newswire)
Dec-07-17 04:47PM	The Swiss Helvetia Fund, Inc. Announces Board Action On By-Law Amendments And Managed Distribution Policy (PR Newswire)
Dec-04-17 04:35PM	The Swiss Helvetia Fund, Inc. Declares Income Distribution And Announces 2018 Stock Repurchase Program (PR Newswire)
Aug-18-17 04:05PM	The Swiss Helvetia Fund, Inc. Announces New Class II Director (PR Newswire)
Jul-07-17 05:11PM	The Swiss Helvetia Fund, Inc. Announces Preliminary Results Of 2017 Annual Stockholder Meeting (PR Newswire)
Jun-27-17 04:05PM	The Swiss Helvetia Fund, Inc. Declares Income Distribution (PR Newswire)
Jun-19-17 08:00AM	The Swiss Helvetia Fund, Inc. Announces ISS Voting Recommendations For 2017 Annual Stockholder Meeting (PR Newswire)
Apr-26-17 08:30AM	The Swiss Helvetia Fund, Inc. Announces Final Results Of One-time Cash Tender Offer (PR Newswire)
Apr-25-17 08:30AM	The Swiss Helvetia Fund, Inc. Announces Expiration And Preliminary Results Of One-Time Cash Tender Offer (PR Newswire)
Apr-17-17 04:05PM	The Swiss Helvetia Fund, Inc. Announces Director Nominations And Resignations (PR Newswire)
Mar-28-17 04:01PM	The Swiss Helvetia Fund, Inc. Announces Commencement of One-Time Cash Tender Offer (PR Newswire)
Mar-22-17 04:10PM	The Swiss Helvetia Fund, Inc. Announces One-Time Cash Tender Offer (PR Newswire)
Dec-23-16 11:23AM	SWISS HELVETIA FUND, INC. Files SEC form 8-K, Changes in Registrant's Certifying Accountant
Dec-06-16 05:05PM	The Swiss Helvetia Fund, Inc. Announces Director Replacement And Planned Director Retirements (PR Newswire)
Dec-05-16 05:21PM	The Swiss Helvetia Fund, Inc. Declares Income Distribution and Announces 2017 Stock Repurchase Program (PR Newswire)
Dec-02-16 01:04PM	SWISS HELVETIA FUND, INC. Financials
Nov-11-16 04:40PM	The Swiss Helvetia Fund, Inc. Announces Decision Not To Call Requested Special Stockholder Meeting (PR Newswire)
Nov-07-16 05:24PM	The Swiss Helvetia Fund, Inc. Announces Intention To Seek Stockholder Approval To Declassify Its Board Of Directors (PR Newswire)
12:04AM	Pros, Cons of Swiss Stocks (The Wall Street Journal)
Nov-02-16 12:41PM	Swiss Helvetia Fund Inc. (SWZ): Bulldog Investors Raises Stake and Asks for Special Meeting (Insider Monkey)
Jun-23-16 06:29PM	The Swiss Helvetia Fund, Inc. Declares Capital Gain Distributions and Announces Appointment of New Director (PR Newswire)
Jun-20-16 05:02PM	SWISS HELVETIA FUND, INC. Files SEC form 8-K, Regulation FD Disclosure
Mar-03-16 02:01PM	Vollgeld: What It Means for Fractional Reserve Banking in Switzerland
Dec-08-15 05:35PM	The Swiss Helvetia Fund, Inc. Declares Income And Capital Gain Distributions And Announces Extension Of Stock Repurchase Program (PR Newswire)
Oct-27-15 06:02AM	SWISS HELVETIA FUND, INC. Files SEC form 8-K, Regulation FD Disclosure
Jun-25-15 05:01PM	The Swiss Helvetia Fund, Inc. Declares Income And Capital Gains Distributions (PR Newswire)
06:02AM	SWISS HELVETIA FUND, INC. Files SEC form 8-K, Regulation FD Disclosure
Mar-17-15 05:12PM	The Swiss Helvetia Fund, Inc. Announces Stock Repurchase Program (PR Newswire)
Jan-23-15 06:01AM	SWISS HELVETIA FUND, INC. Files SEC form 8-K, Regulation FD Disclosure
Jan-22-15 06:26PM	The Swiss Helvetia Fund, Inc. Announces Conference Call To Discuss Recent Market Events (PR Newswire)
Dec-03-14 06:29PM	The Swiss Helvetia Fund, Inc. Declares Capital Gains Distribution (PR Newswire)
Jul-23-14 03:25PM	The Swiss Helvetia Fund, Inc. Announces Revised Net Asset Value Information (PR Newswire)
Jul-08-14 07:00AM	CEF Update: News You Can Use (Morningstar)

The Swiss Helvetia Fund Inc. is a closed-ended equity mutual fund launched and managed by Schroder Investment Management North America Inc. The fund invests in public equity markets of Switzerland. It seeks to invest in stocks of companies operating across diversified sectors. The fund primarily invests in value stocks of companies across all market capitalizations. It employs fundamental analysis with a bottom-up stock picking approach, focusing on factors such as capital appreciation, income, economic and industry trends, quality of management, financial condition, business plan, industry and sector market position, dividend payout ratio, and corporate governance to create its portfolio. The fund benchmarks the performance of its portfolio against the S&P 500 Index and MSCI EAFE Index. It was previously known as The Helvetia Fund, Inc. The Swiss Helvetia Fund Inc. was formed in October 24, 1986 and is domiciled in the United States.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
GOLDSTEIN PHILLIP	Secretary	Jul 06 '26	Buy	5.95	5,980	35,581	119,214	Jul 08 04:05 PM
Dakos Andrew	President and CEO	Jul 02 '26	Buy	5.92	5,000	29,601	131,000	Jul 07 04:27 PM
SELL MORITZ A	Director	Jun 26 '26	Buy	5.88	2,091	12,306	18,246	Jun 30 04:25 PM
SELL MORITZ A	Director	Jun 29 '26	Buy	5.92	2,000	11,850	20,246	Jun 30 04:25 PM
SELL MORITZ A	Director	Jun 18 '26	Buy	5.91	1,853	10,951	16,155	Jun 22 04:23 PM
SELL MORITZ A	Director	Jun 17 '26	Buy	5.91	147	869	14,302	Jun 22 04:23 PM
SELL MORITZ A	Director	Jun 16 '26	Buy	5.96	2,000	11,920	14,155	Jun 17 04:17 PM
SELL MORITZ A	Director	Jun 15 '26	Buy	5.95	155	922	12,155	Jun 17 04:17 PM
SELL MORITZ A	Director	May 29 '26	Buy	6.01	1,000	6,010	12,000	Jun 01 04:25 PM
Dakos Andrew	President and CEO	May 27 '26	Buy	5.97	7,500	44,805	120,500	May 29 04:09 PM
Dakos Andrew	President and CEO	May 28 '26	Buy	5.99	5,500	32,944	126,000	May 29 04:09 PM
Dakos Andrew	President and CEO	May 18 '26	Buy	5.95	4,000	23,800	110,000	May 20 04:14 PM
Dakos Andrew	President and CEO	May 20 '26	Buy	5.96	2,987	17,803	113,000	May 20 04:14 PM
Dakos Andrew	President and CEO	May 19 '26	Buy	5.95	13	77	110,013	May 20 04:14 PM
SELL MORITZ A	Director	Apr 24 '26	Buy	6.07	1,002	6,077	11,000	Apr 27 04:05 PM
Dakos Andrew	President and CEO	Apr 16 '26	Buy	6.06	7,718	46,741	103,000	Apr 20 04:22 PM
Dakos Andrew	President and CEO	Apr 17 '26	Buy	6.09	3,000	18,270	106,000	Apr 20 04:22 PM
Dakos Andrew	President and CEO	Apr 16 '26	Buy	6.04	547	3,304	40,000	Apr 20 04:22 PM
Dakos Andrew	President and CEO	Apr 08 '26	Buy	5.97	4,000	23,900	94,282	Apr 09 04:06 PM
Dakos Andrew	President and CEO	Apr 07 '26	Buy	5.95	2,000	11,900	90,282	Apr 09 04:06 PM
Dakos Andrew	President and CEO	Apr 02 '26	Buy	5.93	4,863	28,828	88	Apr 06 04:38 PM
Dakos Andrew	President and CEO	Apr 06 '26	Buy	5.95	100	595	88,282	Apr 06 04:38 PM
Dakos Andrew	President and CEO	Mar 27 '26	Buy	5.92	5,900	34,928	78,019	Mar 31 04:05 PM
Dakos Andrew	President and CEO	Mar 30 '26	Buy	5.91	5,300	31,312	83,319	Mar 31 04:05 PM
Dakos Andrew	President and CEO	Mar 24 '26	Buy	5.96	6,000	35,750	73,119	Mar 26 04:25 PM
GOLDSTEIN PHILLIP	Secretary	Mar 18 '26	Buy	5.98	10,000	59,800	113,234	Mar 19 04:20 PM
Dakos Andrew	President and CEO	Mar 12 '26	Buy	6.00	3,324	19,944	67,119	Mar 13 05:08 PM
Dakos Andrew	President and CEO	Mar 11 '26	Buy	6.00	1,700	10,200	63,795	Mar 13 05:08 PM
Dakos Andrew	President and CEO	Mar 06 '26	Buy	5.97	12,500	74,625	62,095	Mar 09 04:05 PM
Dakos Andrew	President and CEO	Mar 05 '26	Buy	6.01	12,000	72,120	49,595	Mar 09 04:05 PM
GOLDSTEIN PHILLIP	Secretary	Mar 05 '26	Buy	5.99	10,000	59,900	103,234	Mar 09 04:05 PM
GOLDSTEIN PHILLIP	Secretary	Mar 03 '26	Buy	6.01	5,000	30,050	93,234	Mar 05 04:11 PM
Dakos Andrew	President and CEO	Mar 02 '26	Buy	6.02	14,918	89,762	37,595	Mar 04 04:18 PM
Dakos Andrew	President and CEO	Feb 26 '26	Buy	6.17	5,000	30,850	20,677	Mar 02 06:46 PM
Dakos Andrew	President and CEO	Feb 27 '26	Buy	6.20	2,000	12,400	22,677	Mar 02 06:46 PM
GOLDSTEIN PHILLIP	Director	Feb 23 '26	Buy	6.13	5,000	30,650	87,910	Feb 25 04:26 PM
Dakos Andrew	President and CEO	Feb 23 '26	Buy	6.13	4,000	24,540	14,003	Feb 25 04:06 PM
Dakos Andrew	President and CEO	Feb 24 '26	Buy	6.16	1,674	10,319	15,677	Feb 25 04:06 PM
Dakos Andrew	President and CEO	Feb 19 '26	Buy	6.12	5,000	30,599	7,003	Feb 23 04:05 PM
Dakos Andrew	President and CEO	Feb 20 '26	Buy	6.16	3,000	18,476	10,003	Feb 23 04:05 PM
GOLDSTEIN PHILLIP	Director	Feb 06 '26	Buy	6.07	10,000	60,700	82,910	Feb 10 04:05 PM
Dakos Andrew	President and CEO	Feb 03 '26	Buy	5.97	10,000	59,670	33,453	Feb 05 06:55 PM
Dakos Andrew	President and CEO	Feb 04 '26	Buy	6.03	6,000	36,180	39,453	Feb 05 06:55 PM
SELL MORITZ A	Director	Feb 02 '26	Buy	5.98	1,120	6,698	8,998	Feb 04 04:05 PM
SELL MORITZ A	Director	Feb 03 '26	Buy	5.96	1,000	5,960	9,998	Feb 04 04:05 PM
GOLDSTEIN PHILLIP	Director	Jan 30 '26	Buy	5.92	10,000	59,200	72,910	Feb 03 04:00 PM
CSS LLC/IL	10% Owner	Dec 30 '25	Sale	6.25	12,196	76,180	1,686,971	Dec 31 11:55 AM
CSS LLC/IL	10% Owner	Dec 29 '25	Sale	6.26	7,772	48,665	1,699,167	Dec 31 11:55 AM
CSS LLC/IL	10% Owner	Dec 26 '25	Sale	6.26	21,000	131,436	1,706,939	Dec 29 04:17 PM
CSS LLC/IL	10% Owner	Dec 23 '25	Sale	6.25	5,400	33,775	1,729,039	Dec 29 04:17 PM
CSS LLC/IL	10% Owner	Dec 24 '25	Sale	6.22	1,100	6,843	1,727,939	Dec 29 04:17 PM
CSS LLC/IL	10% Owner	Dec 22 '25	Sale	6.26	1,067	6,678	1,734,439	Dec 29 04:17 PM
CSS LLC/IL	10% Owner	Dec 15 '25	Sale	6.23	7,000	43,600	1,735,506	Dec 17 10:29 AM
SELL MORITZ A	Director	Dec 11 '25	Option Exercise	6.07	7,400	44,918	11,800	Dec 12 05:16 PM
Dakos Andrew	President and CEO	Dec 11 '25	Option Exercise	6.07	35,064	212,838	35,128	Dec 12 05:14 PM
Das Rajeev P	Secretary	Dec 11 '25	Option Exercise	6.07	468	2,841	500	Dec 12 05:09 PM
GOLDSTEIN PHILLIP	Director	Dec 11 '25	Option Exercise	6.07	80,976	491,524	93,224	Dec 12 05:04 PM
SELL MORITZ A	Director	Oct 27 '25	Buy	6.05	1,000	6,055	4,400	Oct 29 04:16 PM

Peers: BGLC BON CNEY YMAT FEAM FSI LOOP NTIC CITR AMTX

| Held by: VXF VTI

Index	-
Market Cap	7.31M
Enterprise Value	3.14M
Income	-6.78M
Sales	2.23M
Book/sh	1.45
Cash/sh	1.28
Dividend Est.	-
Dividend TTM	-
Dividend Ex-Date	-
Dividend Gr. 3/5Y	- -
Payout	-
Employees	24
IPO	Dec 08, 2016

P/E	-
Forward P/E	-
PEG	-
P/S	3.28
P/B	0.95
P/C	1.08
P/FCF	-
EV/EBITDA	-
EV/Sales	1.41
Quick Ratio	7.79
Current Ratio	8.91
Debt/Eq	0.34
LT Debt/Eq	0.31
Option/Short	No / Yes

EPS (ttm)	-1.89
EPS next Y	-1.25
EPS next Q	-0.36
EPS this Y	24.10%
EPS next Y	15.88%
EPS next 5Y	29.96%
EPS past 3/5Y	89.84% 80.37%
Sales past 3/5Y	29.66% 51.10%
EPS Y/Y TTM	75.35%
Sales Y/Y TTM	15.67%
EPS Q/Q	69.40%
Sales Q/Q	1.65%
Earnings	May 12 AMC
EPS/Sales Surpr.	7.33% -21.99%

Insider Own	4.23%
Insider Trans	203.74%
Inst Own	31.30%
Inst Trans	-3.76%
ROA	-92.33%
ROE	-128.03%
ROIC	-66.97%
Gross Margin	58.46%
Oper. Margin	-312.29%
Profit Margin	-304.22%
SMA20	-12.71%
SMA50	-14.71%
SMA200	-41.00%
Trades

Shs Outstand	5.30M
Shs Float	5.08M
Short Float	1.32%
Short Ratio	0.91
Short Interest	0.07M
52W High	6.24 -77.88%
52W Low	1.38 0.00%
Volatility	5.93% 7.46%
ATR (14)	0.12
RSI (14)	36.78
Beta	0.29
Rel Volume	0.40
Avg Volume	73.37K
Volume	29,625

Perf Week	-7.38%
Perf Month	-9.80%
Perf Quarter	-16.36%
Perf Half Y	-38.39%
Perf YTD	-35.51%
Perf Year	-72.56%
Perf 3Y	-98.98%
Perf 5Y	-99.97%
Perf 10Y	-
Recom	1.00
Target Price	6.75
Prev Close	1.40
Price	1.38
Change	-1.43%

Jun-29-26 08:30AM	SenesTech Appoints Jack Karabees as Executive Vice President of Sales (PR Newswire) -5.70%
Jun-04-26 08:00AM	SenesTech Expands Distribution of Evolve Rodent Birth Control into Bermuda (PR Newswire) +6.45%
Jun-03-26 04:05PM	SenesTech Announces Amendment to Equity Incentive Plan Proposal (PR Newswire) -5.49%
May-19-26 04:30PM	SenesTech to Participate in the Lytham Partners Spring 2026 Investor Conference on May 28, 2026 (PR Newswire) +16.99%
May-13-26 08:22PM	SenesTech, Inc. Q1 2026 Earnings Call Summary (Moby) +9.04%
01:00AM	Loading…
01:00AM	SenesTech Inc (SNES) Q1 2026 Earnings Call Highlights: Record Growth in Direct-to-Consumer and ... (GuruFocus.com)
May-12-26 04:05PM	SenesTech Reports Record Direct-to-Consumer and Subscription Growth Following Strategic E-Commerce Transition (PR Newswire)
May-07-26 04:30PM	SenesTech to Report First Quarter 2026 Financial Results on Tuesday, May 12, 2026 (PR Newswire) +34.01% -12.18%
08:30AM	SenesTech Appoints Michael Edell as President and Chief Executive Officer to Drive Revenue Growth and Scalable Sales Channels (PR Newswire)
Mar-13-26 08:30AM	SenesTech, Inc. Q4 2025 Earnings Call Summary (Moby) -15.04%
Mar-12-26 11:03PM	SenesTech Inc (SNES) Q4 2025 Earnings Call Highlights: E-commerce Surge and Strategic Growth ... (GuruFocus.com) +9.71%
04:05PM	SenesTech Announces 2025 Financial Results Driven by Strong Growth in E-Commerce (PR Newswire)
Mar-09-26 04:15PM	SenesTech to Report Fourth Quarter and Fiscal Year 2025 Financial Results on Thursday, March 12, 2026 (PR Newswire) -6.60%
Feb-18-26 08:00AM	SenesTech Reports Significant Reductions in Rodent Activity Following Evolve Deployments in Urban Field Studies (PR Newswire)
Feb-10-26 08:00AM	SenesTech Strengthens Direct-to-Consumer Commercial Strategy by Directly Managing Amazon Sales of Evolve Rat and Evolve Mouse (PR Newswire)
08:00AM	Loading…
Feb-02-26 08:00AM	SenesTech's Evolve Approved in New Zealand (PR Newswire) +9.73%
Jan-28-26 04:05PM	SenesTech Announces CEO Transition Plan (PR Newswire)
Nov-11-25 09:00AM	SenesTech Expands International Reach with the Addition of the Belize Raptor Center as an Official Distributor of Evolve Rat Birth Control (PR Newswire) -8.19%
12:04AM	SenesTech Inc (SNES) Q3 2025 Earnings Call Highlights: Record Revenue Growth and Strategic Expansion (GuruFocus.com)
Nov-10-25 04:05PM	SenesTech Reports Third Quarter 2025 Financial Results with Record Revenue and Adjusted EBITDA (PR Newswire)
12:00PM	SenesTech's Evolve Rat Birth Control Now Available Online at Lowes.com (PR Newswire)
Nov-07-25 07:27AM	SenesTech Inc (SNES) Q3 2025: Everything You Need To Know Ahead Of Earnings (GuruFocus.com) +11.51%
Nov-06-25 05:25PM	Celanese (CE) Beats Q3 Earnings Estimates (Zacks) -5.59%
Nov-05-25 08:10AM	Green Plains Renewable Energy (GPRE) Q3 Earnings Top Estimates (Zacks)
Nov-04-25 06:35PM	Ashland (ASH) Q4 Earnings Lag Estimates (Zacks) -6.08%
Nov-03-25 04:15PM	SenesTech to Report Third Quarter 2025 Financial Results on Monday, November 10, 2025 (PR Newswire)
Oct-31-25 07:05AM	Linde (LIN) Q3 Earnings and Revenues Top Estimates (Zacks)
Oct-13-25 08:00AM	Swampscott Launches Pilot of SenesTech's Innovative Rat Birth Control at Firehouse and Local School (PR Newswire) +7.03%
Sep-17-25 04:15PM	SenesTech to Participate in the Lytham Partners Fall 2025 Investor Conference on September 30, 2025 (PR Newswire)
Sep-10-25 08:00AM	SenesTech's Evolve Rat Birth Control Now Available Online at HomeDepot.com (PR Newswire)
08:00AM	Loading…
Sep-02-25 08:00AM	SenesTech's Evolve Deployments Expanded to Additional Chicago Neighborhoods (PR Newswire)
Aug-18-25 04:15PM	SenesTech to Participate in the Lytham Partners 2025 Consumer & Technology Investor Summit on August 19, 2025 (PR Newswire)
Aug-08-25 03:41AM	SenesTech Inc (SNES) Q2 2025 Earnings Call Highlights: Record Revenue and Strategic Expansion (GuruFocus.com) -12.99%
Aug-07-25 04:05PM	SenesTech Reports Second Quarter 2025 Financial Results with Record Revenue and Record Gross Profit Margins (PR Newswire)
Aug-05-25 07:10PM	SenesTech Announces Closing of Warrant Exercise for $6.3 Million in Gross Proceeds (PR Newswire) -12.85%
08:00AM	SenesTech Announces Warrant Exercise for $6.3 Million in Gross Proceeds (PR Newswire)
Jul-31-25 04:15PM	SenesTech to Report Second Quarter 2025 Financial Results on Thursday, August 7, 2025 (PR Newswire)
Jul-01-25 05:46PM	SenesTech Announces Closing of Warrant Exercise for $4.4 Million in Gross Proceeds (PR Newswire)
08:00AM	SenesTech Announces Warrant Exercise for $4.4 Million in Gross Proceeds (PR Newswire)
Jun-26-25 08:00AM	SenesTech's Evolve Rodent Birth Control Proven in Urban Rodent Hotspots from Hong Kong to San Francisco (PR Newswire) +30.94%
Jun-25-25 08:00AM	SenesTech and Irvine Campus Housing Authority Conclude Successful Field Trial of Evolve Rat Birth Control at UC Irvine (PR Newswire)
Jun-13-25 08:00AM	Baltimore Expands Use of Evolve Rodent Birth Control Following Successful Pilot (PR Newswire) +21.43%
Jun-11-25 08:00AM	SenesTech Announces Bradley Caldwell, Inc. as New U.S. Distributor for Evolve Rodent Fertility Control Products (PR Newswire)
May-27-25 04:15PM	SenesTech to Participate in the Lytham Partners Spring 2025 Investor Conference on May 29, 2025 (PR Newswire)
May-09-25 03:47AM	SenesTech Inc (SNES) Q1 2025 Earnings Call Highlights: Evolve Product Line Drives Revenue Surge ... (GuruFocus.com) +8.18%
May-08-25 04:05PM	SenesTech Reports First Quarter 2025 Financial Results 40% Revenue Growth in Evolve, Record Gross Profit Margins of 65%, and Continued Progress Toward Profitability (PR Newswire)
May-07-25 09:00AM	SenesTech Announces Exclusive Distribution Agreement and Initial Order for Evolve Soft Bait in Indonesia (PR Newswire)
May-01-25 04:15PM	SenesTech to Report First Quarter 2025 Financial Results on Thursday, May 8, 2025 (PR Newswire) +8.11%
Apr-17-25 09:00AM	SenesTech's Evolve Deployed in Chicago Neighborhoods (PR Newswire)
Mar-31-25 04:15PM	SenesTech to Participate in the Lytham Partners 2025 Industrials & Basic Materials Investor Summit on April 1, 2025 (PR Newswire)
Mar-13-25 03:09AM	SenesTech Inc (SNES) Q4 2024 Earnings Call Highlights: Record Revenue Growth and Strategic Expansion (GuruFocus.com)
Mar-12-25 04:05PM	SenesTech Announces Record Fourth Quarter and Full Year 2024 Financial Results with 70% Quarterly Revenue Growth; Gross Profit Margins of 61%; Reduction in Operating Expenses; and Dramatic Improvement in Adjusted EBITDA (PR Newswire)
Mar-10-25 08:00AM	SenesTech Announces Warrant Exercise for $1.1 Million in Gross Proceeds (PR Newswire) -21.93%
Mar-06-25 04:15PM	SenesTech to Report Fourth Quarter and Fiscal Year 2024 Financial Results on Wednesday, March 12, 2025 (PR Newswire)
Feb-25-25 09:25AM	SenesTech Expands its Rapidly Growing Global Footprint and Clears Major Regulatory Hurdle, Paving the Way for Use in Australia and New Zealand (PR Newswire) +5.77%
Feb-18-25 08:45AM	SenesTech Expands into Warehousing and Distribution Sector with Multi-Pallet Initial Shipment of Evolve Rodent Birth Control (PR Newswire)
Feb-10-25 09:20AM	SenesTech Expands E-Commerce Presence with Evolve Rodent Birth Control Now Available on TractorSupply.com (PR Newswire) -8.57%
Feb-04-25 11:30AM	SenesTech Expands Global Footprint for Evolve Rodent Birth Control: Signs Letter of Intent with SMark to Enter Indian Rodent Pest Control Market (PR Newswire) +8.60%
Jan-21-25 08:00AM	Baltimore Adopts Evolve Rodent Birth Control for Integrated Pest Management Targeting Rodent Overpopulation (PR Newswire) +11.61%
Jan-14-25 08:00AM	Bug Off Pest Control Center of New York City to Supply New York City with Evolve (PR Newswire)
Jan-10-25 04:15PM	Joshua M. Moss Joining the SenesTech Board of Directors (PR Newswire) -6.60%
Nov-13-24 02:22AM	SenesTech Inc (SNES) Q3 2024 Earnings Call Highlights: Record Revenue and Strategic Expansion (GuruFocus.com) -7.12%
Nov-12-24 04:05PM	SenesTech Announces Third Quarter 2024 Financial Results (PR Newswire) -9.18%
09:00AM	SenesTech Launches Evolve Rodent Birth Control on Walmart Marketplace (PR Newswire)
Nov-06-24 10:36AM	SenesTech (SNES): Why Small Positions May Not Be the Safe Bet You Think (Insider Monkey) +8.37%
Nov-05-24 04:15PM	SenesTech to Report Third Quarter 2024 Financial Results on Tuesday, November 12, 2024 (PR Newswire)
Oct-31-24 08:30AM	Evolve Registered in Hong Kong; Offering a Revolutionary Non-Lethal Rodent Control Solution (PR Newswire)
Oct-09-24 06:03PM	SenesTech Inc (SNES) Q2 2024 Earnings Call Highlights: Record Revenue Growth and Strategic ... (GuruFocus.com)
Oct-08-24 09:00AM	New York City to Pursue Rat Contraception Pilot Program (PR Newswire)
Sep-23-24 04:15PM	SenesTech to Participate in the Lytham Partners Fall 2024 Investor Conference on October 1, 2024 (PR Newswire) +20.83%
Aug-23-24 04:00PM	SenesTech Announces Closing of Warrant Exercise for $2.3 Million in Gross Proceeds (PR Newswire) -15.46% -9.76%
Aug-08-24 04:05PM	SenesTech Announces Second Quarter 2024 Financial Results (PR Newswire)
Aug-01-24 04:15PM	SenesTech to Report Second Quarter 2024 Financial Results on Thursday, August 8, 2024 (PR Newswire) -5.26%
Jul-31-24 08:00AM	IBN Announces Latest Episode of The GotStocks Podcast featuring Joel Fruendt, CEO of SenesTech Inc. (GlobeNewswire)
Jul-23-24 11:30AM	SenesTech Announces Reverse Stock Split (PR Newswire) -24.25%
Jun-26-24 09:00AM	SenesTech's Evolve Fertility Control Solution for Rats To Be Deployed in the U.S. Virgin Islands (PR Newswire)
Jun-12-24 07:00AM	Presenting on the Emerging Growth Conference 72 Day 2 on June 13 Register Now (GlobeNewswire)
Jun-11-24 07:00AM	Presenting on the Emerging Growth Conference 72 Day 1 on June 12 Register Now (GlobeNewswire)
May-30-24 12:10PM	SenesTech (SNES) to Gain Market With Evolve's Launch on Amazon (Zacks)
May-23-24 09:00AM	SenesTech to Participate in the Lytham Partners Spring 2024 Investor Conference on May 30, 2024 (PR Newswire) -7.56%
May-22-24 09:00AM	SenesTech Launches Evolve Fertility Control Solution for Rats on Amazon, the World's Largest Online Retailer (PR Newswire) +8.09%
May-20-24 09:46AM	Should You Add SenesTech (SNES) to Your Portfolio? (Insider Monkey)
May-12-24 09:32AM	SenesTech, Inc. (NASDAQ:SNES) Q1 2024 Earnings Call Transcript (Insider Monkey)
May-09-24 04:05PM	SenesTech Announces First Quarter 2024 Financial Results (PR Newswire) +9.06% -26.19%
May-02-24 04:15PM	SenesTech to Report First Quarter 2024 Financial Results on Thursday, May 9, 2024 (PR Newswire) +9.52%
09:00AM	SenesTech Launches Evolve Mouse (PR Newswire)
Apr-03-24 07:00AM	Presenting on the Emerging Growth Conference 69 Day 2 on April 4 Register Now (GlobeNewswire)
Apr-02-24 09:00AM	SenesTech to Present at the Emerging Growth Conference on April 3, 2024 (PR Newswire)
07:00AM	Presenting on the Emerging Growth Conference 69 Day 1 on April 3 Register Now (GlobeNewswire)
Mar-26-24 09:00AM	SenesTech Signs Wilco Distributing for Evolve and ContraPest Distribution in Agriculture and Professional Rodent Pest Management Market (PR Newswire)
Mar-06-24 07:00AM	Presenting on the Emerging Growth Conference 68 Day 2 on March 7 Register Now (GlobeNewswire)
Mar-05-24 09:00AM	SenesTech to Present at the Emerging Growth Conference on March 6, 2024 (PR Newswire)
07:00AM	Presenting on the Emerging Growth Conference 68 Day 1 on March 6 Register Now (GlobeNewswire)
Feb-24-24 08:15AM	SenesTech, Inc. (NASDAQ:SNES) Q4 2023 Earnings Call Transcript (Insider Monkey)
Feb-21-24 04:05PM	SenesTech Announces 2023 Financial Results (PR Newswire) +8.49% -19.84%
Feb-20-24 10:17AM	SenesTech (SNES) Expands in the Netherlands With Q-chem Deal (Zacks)
Feb-15-24 04:15PM	SenesTech to Report Fourth Quarter and Fiscal Year 2023 Financial Results on Wednesday, February 21, 2024 (PR Newswire)
09:00AM	SenesTech Announces Exclusive Distribution Agreement for Evolve Soft Bait in The Netherlands (PR Newswire)
Feb-12-24 09:00AM	SenesTech Approved as Vendor for All Ace Hardware Stores (PR Newswire) +12.26%
Feb-08-24 09:00AM	SenesTech Announces Exclusive Distribution Agreement for Evolve Soft Bait in Australia and New Zealand (PR Newswire) -8.93%

SenesTech, Inc. engages in the development and commercialization of proprietary technology for the management of animal pest populations. The firm focuses on rat populations through fertility control. It offers its ContraPest product to residential and commercial sectors such as animal, structural, and food markets. The company was founded by Loretta P. Mayer and Cheryl A. Dyer on July 27, 2004 and is headquartered in Phoenix, AZ.

President & CEOMr. Michael Edell

Executive VPMr. Thomas C. Chesterman M.B.A.

Vice President of SalesMr. Bryan Di Menna

Investor RelationsRobert Blum

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Edell Michael	Chief Executive Officer	Jul 07 '26	Buy	1.43	1,000	1,430	5,000	Jul 08 05:01 PM
GLENBROOK CAPITAL MANAGEMENT	10% Owner	Jun 30 '26	Buy	1.51	35,000	52,731	1,022,824	Jul 02 08:00 PM
GLENBROOK CAPITAL MANAGEMENT	10% Owner	Jun 22 '26	Buy	1.66	5,000	8,296	962,408	Jun 22 08:00 PM
GLENBROOK CAPITAL MANAGEMENT	10% Owner	Jun 17 '26	Buy	1.61	3,264	5,268	957,408	Jun 22 08:00 PM
Edell Michael	Chief Executive Officer	Jun 08 '26	Buy	1.55	1,000	1,550	4,000	Jun 09 04:15 PM
GLENBROOK CAPITAL MANAGEMENT	10% Owner	Jun 05 '26	Buy	1.57	13,159	20,685	947,144	Jun 08 06:13 PM
GLENBROOK CAPITAL MANAGEMENT	10% Owner	Jun 04 '26	Buy	1.65	8,230	13,547	933,985	Jun 08 06:13 PM
GLENBROOK CAPITAL MANAGEMENT	10% Owner	Jun 08 '26	Buy	1.61	7,000	11,304	954,144	Jun 08 06:13 PM
GLENBROOK CAPITAL MANAGEMENT	10% Owner	May 14 '26	Buy	1.72	15,000	25,862	908,635	May 18 08:11 PM
GLENBROOK CAPITAL MANAGEMENT	10% Owner	May 18 '26	Buy	1.59	10,000	15,878	925,755	May 18 08:11 PM
GLENBROOK CAPITAL MANAGEMENT	10% Owner	May 15 '26	Buy	1.65	7,120	11,747	915,755	May 18 08:11 PM
Edell Michael	Chief Executive Officer	May 14 '26	Buy	1.70	2,000	3,398	2,000	May 18 04:40 PM
Edell Michael	Chief Executive Officer	May 15 '26	Buy	1.61	1,000	1,615	3,000	May 18 04:40 PM
GLENBROOK CAPITAL MANAGEMENT	10% Owner	Apr 28 '26	Buy	1.47	3,000	4,407	893,635	Apr 30 07:19 PM
GLENBROOK CAPITAL MANAGEMENT	10% Owner	Mar 13 '26	Buy	1.95	146,249	285,434	865,850	Mar 17 08:10 PM
GLENBROOK CAPITAL MANAGEMENT	10% Owner	Mar 17 '26	Buy	1.79	19,725	35,355	890,635	Mar 17 08:10 PM
GLENBROOK CAPITAL MANAGEMENT	10% Owner	Mar 16 '26	Buy	1.86	5,060	9,392	870,910	Mar 17 08:10 PM
GLENBROOK CAPITAL MANAGEMENT	10% Owner	Feb 17 '26	Buy	2.29	40,807	93,493	659,117	Feb 19 07:57 PM
GLENBROOK CAPITAL MANAGEMENT	10% Owner	Feb 19 '26	Buy	2.40	34,613	83,140	704,211	Feb 19 07:57 PM
GLENBROOK CAPITAL MANAGEMENT	10% Owner	Feb 18 '26	Buy	2.29	10,481	24,001	669,598	Feb 19 07:57 PM
GLENBROOK CAPITAL MANAGEMENT	10% Owner	Feb 13 '26	Buy	1.89	15,390	29,106	633,700	Feb 13 05:20 PM
GLENBROOK CAPITAL MANAGEMENT	10% Owner	Feb 11 '26	Buy	1.73	8,000	13,874	610,354	Feb 13 05:20 PM
GLENBROOK CAPITAL MANAGEMENT	10% Owner	Feb 12 '26	Buy	1.72	7,956	13,688	618,310	Feb 13 05:20 PM
GLENBROOK CAPITAL MANAGEMENT	10% Owner	Feb 04 '26	Buy	1.82	5,685	10,373	599,470	Feb 06 05:40 PM
GLENBROOK CAPITAL MANAGEMENT	10% Owner	Feb 05 '26	Buy	1.77	2,884	5,106	602,354	Feb 06 05:40 PM
GLENBROOK CAPITAL MANAGEMENT	10% Owner	Feb 02 '26	Buy	1.98	42,739	84,418	593,785	Feb 03 05:27 PM
GLENBROOK CAPITAL MANAGEMENT	10% Owner	Jan 30 '26	Buy	1.87	5,399	10,106	551,046	Feb 03 05:27 PM
Leach Jacob Steven	Director	Nov 18 '25	Sale	2.71	62	168	0	Nov 19 07:48 PM
Szot Matthew K	Director	Nov 14 '25	Sale	2.75	1	3	0	Nov 17 03:00 PM

PRQR

ProQR Therapeutics N.V

SWZ

Total Return Securities Fund

SNES

SenesTech Inc

Upgrade your Finviz experience